AGPU

Axe Compute Inc. · NASDAQ · Technology · USD · 10-K for 2025, filed 2026-03-31

Figures on this page computed 2026-11-08 12:41 UTC

Last close

6.05USD

Market data, 2026-11-05

Except where said otherwise: 10-K for 2025, filed 2026-03-31

  • n/aP/E

    We do not hold this figure for this company, so there is nothing to place.

    Price / Earnings per Share (diluted)

    Source
    computed
    Fiscal year
    2025
    Accession
    0001171843-26-002094
    Reported in
    USD
    • computed
    • 10-K for 2025, filed 2026-03-31

    The filing itself

  • n/aROIC

    We do not hold this figure for this company, so there is nothing to place.

    NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash

    Source
    computed
    Fiscal year
    2025
    Accession
    0001171843-26-002094
    Reported in
    USD
    • 10-K for 2025, filed 2026-03-31
    • 10-K for 2025, filed 2026-03-31
    • 10-K for 2025, filed 2026-03-31
    • 10-Q for 2025, filed 2026-08-14
    • 10-K for 2025, filed 2026-03-31
    • 10-Q for 2025, filed 2026-08-14

    The filing itself

  • -186053.5%Net margin

    Net Income / Revenue x 100

    Source
    computed
    Fiscal year
    2025
    Accession
    0001171843-26-002094
    Reported in
    USD
    • 10-K for 2025, filed 2026-03-31
    • 10-K for 2025, filed 2026-03-31

    The filing itself

  • -7882.9%FCF margin

    Free Cash Flow / Revenue x 100

    Source
    computed
    Fiscal year
    2025
    Accession
    0001171843-26-002094
    Reported in
    USD
    • 10-K for 2025, filed 2026-03-31
    • 10-K for 2025, filed 2026-03-31

    The filing itself

  • 0.03Debt/equity

    Total Debt / Shareholders' Equity

    Source
    computed
    Fiscal year
    2025
    Accession
    0001171843-26-002094
    Reported in
    USD
    • 10-K for 2025, filed 2026-03-31
    • 10-Q for 2025, filed 2026-08-14

    The filing itself

  • n/aDividend yield

    We do not hold this figure for this company, so there is nothing to place.

    Source
    computed
    Taken on
    2026-11-07
    Reported in
    USD
    • computed

What it sells, to whom

lens 8 of 9

What it sells

2
Drug Discovery Services Segment84,812 USD100%
Compute Services and Treasury Management Segment0 USD0%

Each band is a share of itself. A segment and a place are two cuts of the same revenue, so they are never added together.

2 segments, 0 places and 0 named customers, each as the filer published it.

2 segments, 0 places and 0 named customers, each as the filer published it.

Every figure in this lens

Except where said otherwise: 10-K for 2024, filed 2026-03-31

  • Drug Discovery Services Segment84,812
    Source
    filed
    Statement
    segments
    Fiscal year
    2024
    Accession
    0001171843-26-002094
    Reported in
    USD

    The filing itself

  • Compute Services and Treasury Management Segment0
    Source
    filed
    Statement
    segments
    Fiscal year
    2024
    Accession
    0001171843-26-002094
    Reported in
    USD

    The filing itself

Filed figures cite the filing they come from; figures marked Market data are quotes as of the date shown. Not a recommendation and not advice.

Past figures are not a forecast. Anything we modelled is labelled as ours. You can lose money on any security.